A PHASE-I CLINICAL-TRIAL OF RECOMBINANT INTERLEUKIN-2 FOLLOWING HIGH-DOSE CHEMO-RADIOTHERAPY FOR HEMATOLOGICAL MALIGNANCY - APPLICABILITY TO THE ELIMINATION OF MINIMAL RESIDUAL DISEASE

被引:100
作者
GOTTLIEB, DJ
BRENNER, MK
HESLOP, HE
BIANCHI, ACM
BELLOFERNANDEZ, C
MEHTA, AB
NEWLAND, AC
GALAZKA, AR
SCOTT, EM
HOFFBRAND, AV
PRENTICE, HG
机构
[1] LONDON HOSP,DEPT HAEMATOL,LONDON E1 1BB,ENGLAND
[2] GLAXO INST MOLEC BIOL,GENEVA,SWITZERLAND
关键词
D O I
10.1038/bjc.1989.324
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:610 / 615
页数:6
相关论文
共 19 条
  • [1] ADLER A, 1988, BLOOD, V71, P709
  • [2] APPELBAUM FR, 1988, BLOOD, V72, P179
  • [3] TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A PROSPECTIVE CONTROLLED TRIAL OF BONE-MARROW TRANSPLANTATION VERSUS CONSOLIDATION CHEMOTHERAPY
    CHAMPLIN, RE
    HO, WG
    GALE, RP
    WINSTON, D
    SELCH, M
    MITSUYASU, R
    LENARSKY, C
    ELASHOFF, R
    ZIGHELBOIM, J
    FEIG, SA
    [J]. ANNALS OF INTERNAL MEDICINE, 1985, 102 (03) : 285 - 291
  • [4] DONOHUE JH, 1983, J IMMUNOL, V130, P2203
  • [5] GARSON OM, 1987, IN PRESS CANCER GENE
  • [6] THE HEMODYNAMIC-EFFECTS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    GAYNOR, ER
    VITEK, L
    STICKLIN, L
    CREEKMORE, SP
    FERRARO, ME
    THOMAS, JX
    FISHER, SG
    FISHER, RI
    [J]. ANNALS OF INTERNAL MEDICINE, 1988, 109 (12) : 953 - 958
  • [7] AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA IN REMISSION
    GORIN, NC
    HERVE, P
    AEGERTER, P
    GOLDSTONE, A
    LINCH, D
    MARANINCHI, D
    BURNETT, A
    HELBIG, W
    MELONI, G
    VERDONCK, LF
    DEWITTE, T
    RIZZOLI, V
    CARELLA, A
    PARLIER, Y
    AUVERT, B
    GOLDMAN, J
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (02) : 385 - 395
  • [8] HESLOP HE, 1988, J IMMUNOL, V140, P3461
  • [9] INTERLEUKIN-2 ENHANCES CYTOTOXIC CELL-FUNCTION INVITRO AFTER T-CELL DEPLETED MARROW TRANSPLANTATION
    LEGER, O
    DREXLER, HG
    REITTIE, JE
    SECKERWALKER, L
    PRENTICE, HG
    BRENNER, MK
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1987, 67 (03) : 273 - 279
  • [10] HIGH-DOSE RECOMBINANT INTERLEUKIN-2 IN THE TREATMENT OF PATIENTS WITH DISSEMINATED CANCER - RESPONSES, TREATMENT-RELATED MORBIDITY, AND HISTOLOGIC-FINDINGS
    LOTZE, MT
    CHANG, AE
    SEIPP, CA
    SIMPSON, C
    VETTO, JT
    ROSENBERG, SA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (22): : 3117 - 3124